Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART)

被引:28
作者
López-Vélez, R [1 ]
Casado, JL [1 ]
Pintado, V [1 ]
机构
[1] Hosp Ramon y Cajal, E-28034 Madrid, Spain
关键词
D O I
10.1046/j.1198-743x.2001.00270.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:394 / 395
页数:2
相关论文
共 10 条
[1]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[2]   Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy [J].
Casado, JL ;
Lopez-Velez, R ;
Pintado, V ;
Quereda, C ;
Antela, A ;
Moreno, S .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (03) :202-205
[3]   Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy [J].
Kaplan, JE ;
Hanson, D ;
Dworkin, MS ;
Frederick, T ;
Bertolli, J ;
Lindegren, ML ;
Holmberg, S ;
Jones, JL .
CLINICAL INFECTIOUS DISEASES, 2000, 30 :S5-S14
[4]   Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain [J].
Lopez-Velez, R ;
Perez-Molina, JA ;
Guerrero, A ;
Baquero, F ;
Villarrubia, J ;
Escribano, L ;
Bellas, C ;
Perez-Corral, F ;
Alvar, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (04) :436-443
[5]  
MERINO E, 2001, 8 C RETR OPP INF CHI
[6]  
PINEDA JA, 2000, 13 INT AIDS C DURB
[7]  
TORTAJADA C, 2001, 8 C RETR OPP INF CHI
[8]   Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals [J].
Tumbarello, M ;
Tacconelli, E ;
Bertagnolio, S ;
Cauda, R .
AIDS, 2000, 14 (18) :2948-2949
[9]   Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy [J].
Villanueva, JL ;
Alarcón, A ;
Bernabeu-Wittel, M ;
Cordero, E ;
Prados, D ;
Regordán, C ;
Alvar, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (10) :798-801
[10]  
*WHO, 1999, WKLY EPIDEMIOL REC, V74, P365